Komori
Imura & (3955) · InitiativeAdvanced

Strengthening Profitability

First written in FY2017-Q1. 13 of 29 entries say "Advanced", first in FY2017-Q2. Latest entry: FY2024.

29entries
9years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAdvancedFY2017-Q2 – FY2018-Q3OtherFY2022-Q2 – FY2023-Q3AdvancedFY2024-Q1 – FY20242016: 320162017: 320172018: 420182019: 320192020: 420202021: 420212022: 320222023: 420232024: 12024
Same theme, other companies
Improving Profitability by Selecting and Organizing Low-Margin Projects and Managing Costs Across the CompanyA theme 401 companies write about · 3 as a headwind · 427 as a tailwind

91 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 188 companies compared. The sentences above are computed from all 188.Comparing 200 of the theme's 430 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2024AdvancedAnnual report

    「In terms of earnings, although material prices increased, operating profit was ¥981 million, up 11.5% from the previous fiscal year, due to controls on subcontract processing costs resulting from greater in-house production and lower fixed costs.」

    Despite higher material prices, operating profit in the Package Solutions business increased 11.5% year on year due to lower subcontract processing costs from greater in-house production and lower fixed costs.
  2. FY2024-Q3AdvancedAnnual report

    「Although sales at the subsidiary engaged in printing materials for medical institutions recovered, the subsidiary engaged in manufacturing and selling inserting machines and the information systems business posted lower sales, resulting in net sales of ¥1,282 million, up 1.5% year on year. In terms of earnings, efforts to improve efficiency across the Group, including the transfer of production functions at the medical-institution printing subsidiary, also proved effective, and operating profit was ¥57 million, up 197.2% year on year.」

    In Other businesses, some subsidiaries and the information systems business posted lower sales, but operating profit increased 197.2% year on year as efficiency measures, including the transfer of production functions, proved effective.
  3. FY2024-Q2AdvancedAnnual report

    「Although sales at the subsidiary engaged in printing materials for medical institutions recovered, the subsidiary engaged in manufacturing and selling inserting machines and the information systems business posted lower sales, resulting in net sales of ¥850 million, down 3.9% year on year. In terms of earnings, Group-wide restructuring efforts, including the transfer of production functions at the medical-institution printing subsidiary, proved effective, and operating profit was ¥35 million, up 308.7% year on year.」

    In Other businesses, sales declined, while operating profit increased 308.7% year on year as restructuring measures, including the transfer of production functions within the Group, proved effective.
  4. FY2024-Q1AdvancedAnnual report

    「Although the subsidiary engaged in printing materials for medical institutions increased sales, the subsidiary engaged in manufacturing and selling inserting machines and the information systems business posted lower sales, resulting in net sales of ¥462 million, down 1.7% year on year. In terms of earnings, the factors that had caused costs in the previous fiscal year, including the transfer of production functions and relocation of headquarters at the medical-institution printing subsidiary, were eliminated in the current fiscal year, and operating profit was ¥18 million, compared with ¥0 million in the previous fiscal year.」

    In Other businesses, although sales declined, operating profit improved from ¥0 million in the previous fiscal year to ¥18 million as cost factors associated with restructuring and the relocation of headquarters in the previous fiscal year were eliminated.
  5. FY2023WorsenedAnnual report

    「Driven primarily by the recovery in performance at the subsidiary engaged in manufacturing and selling inserting machines, net sales were ¥1,656 million, up 20.4% from the previous fiscal year. In terms of earnings, temporary costs arose from restructuring within the Group, including the transfer of production functions and the relocation of headquarters at the subsidiary engaged in printing materials for medical institutions, and operating profit was ¥4 million, down 85.0% from the previous fiscal year.」

    In Other businesses, sales increased, while operating profit declined 85.0% from the previous fiscal year due to temporary restructuring costs.
  6. FY2023-Q3RestatedAnnual report

    「As performance at the subsidiary engaged in manufacturing and selling inserting machines recovered, net sales were ¥1,264 million, up 25.3% year on year. In terms of earnings, temporary costs were incurred as a result of restructuring within the Group, including the transfer of production functions at the subsidiary engaged in printing materials for medical institutions, and operating profit was ¥19 million, down 44.4% year on year.」

    While recovery at the inserting-machine sales subsidiary continued, operating profit declined 44.4% year on year due to temporary costs associated with the transfer of production functions and other measures at the medical-institution printing subsidiary.
  7. FY2023-Q2Continued recovery at subsidiaries and continued restructuring costsAnnual report

    「As performance at the subsidiary engaged in manufacturing and selling inserting machines recovered, net sales increased 23.9% year on year to ¥884 million. However, at the subsidiary engaged in printing materials for medical institutions, temporary relocation costs and other expenses were incurred as a result of restructuring within the Group, including the transfer of production functions, and operating profit was ¥8 million, down 77.5% year on year.」

    Sales increased due to the recovery at the inserting-machine sales subsidiary, while operating profit declined substantially due to temporary costs associated with the transfer of production functions and other measures at the medical-institution printing subsidiary.
  8. FY2023-Q1Recovery in subsidiary performance and restructuring costs incurred concurrentlyAnnual report

    「As performance at the subsidiary engaged in manufacturing and selling inserting machines recovered, net sales increased 14.0% year on year to ¥469 million. However, at the subsidiary engaged in printing materials for medical institutions, temporary relocation costs and other expenses were incurred as a result of restructuring within the Group, including the transfer of production functions, and operating profit was ¥0 million, down 98.2% year on year.」

    In Other businesses, performance at the inserting-machine sales subsidiary recovered, while temporary costs associated with restructuring at the medical-institution printing subsidiary reduced operating profit to almost zero.
  9. FY2022-Q3RestatedAnnual report

    「Both the information systems business and the 2 subsidiaries were forced to report lower sales. Although net sales were ¥1,009 million, down 19.9% year on year, operating profit was ¥34 million, up 0.2%, due to controls on selling, general and administrative expenses and an improved gross profit margin.」

    In Other businesses, sales continued to decline, while operating profit increased 0.2% year on year due to controls on selling, general and administrative expenses and an improved gross profit margin.
  10. FY2022-Q2Profit Growth Despite Revenue DeclineAnnual report

    「Both the information systems business and the 2 subsidiaries were forced to report lower sales. Although net sales were ¥713 million, down 18.0% year on year, operating profit was ¥38 million, up 121.8%, due to controls on selling, general and administrative expenses and an improved gross profit margin.」

    In Other businesses, net sales declined 18.0% due to lower sales at the information systems business and the 2 subsidiaries, while operating profit increased 121.8% due to controls on selling, general and administrative expenses and an improved gross profit margin.
  11. FY2022-Q1WorsenedAnnual report

    「(Other) Both the information systems business and the 2 subsidiaries were forced to report lower sales. Net sales were ¥412 million, down 25.6% year on year, and operating profit was ¥31 million, down 12.5%.」

    In Other businesses, both the information systems business and the 2 subsidiaries posted lower sales, and net sales and operating profit declined year on year.
  12. FY2021WorsenedAnnual report

    「Although the information systems business posted higher sales, the 2 subsidiaries were forced to report lower sales due to weak demand. Net sales were ¥1,636 million, down 9.5% from the previous fiscal year, and operating profit was ¥33 million, down 69.8%.」

    In Other businesses, the 2 subsidiaries were affected by weak demand, with net sales down 9.5% and operating profit down 69.8%.
  13. FY2021-Q3RestatedAnnual report

    「As the subsidiary engaged in printing materials for medical institutions was affected by the decline in demand caused by the COVID-19 pandemic, net sales were ¥1,259 million, down 4.9% year on year, and operating profit was ¥34 million, down 52.6%.」

    In Other businesses, the subsidiary was affected by the decline in demand caused by the COVID-19 pandemic, resulting in lower sales and lower profit.
  14. FY2021-Q2WorsenedAnnual report

    「(Other) As the 2 subsidiaries were affected by the decline in demand caused by the COVID-19 pandemic, net sales were ¥870 million, down 4.9% year on year, and operating profit was ¥17 million, down 75.7%.」

    In Other businesses, the 2 subsidiaries were affected by the decline in demand caused by the COVID-19 pandemic, and both net sales and operating profit fell below the previous year.
  15. FY2021-Q1AdvancedAnnual report

    「Driven by increased sales of systems-related products and strong sales of inserting machines at the subsidiary, among other factors, net sales were ¥554 million, up 33.7% year on year, and operating profit was ¥36 million, up 135.3%.」

    In Other businesses, increased sales of systems-related products and inserting machines were strong, and net sales and operating profit exceeded the previous year.
  16. FY2020AdvancedAnnual report

    「As both the information systems business and the 2 subsidiaries posted higher sales, net sales were ¥1,807 million, up 7.6% year on year, and operating profit was ¥109 million, up 29.0%.」

    In Other businesses, the information systems business and both subsidiaries posted higher sales, and net sales and operating profit exceeded the previous year.
  17. FY2020-Q3AdvancedAnnual report

    「As both the information systems business and the 2 subsidiaries posted higher sales, net sales were ¥1,324 million, up 8.8% year on year, and operating profit was ¥73 million, up 65.8%.」

    In Other businesses, the information systems business and both subsidiaries posted higher sales, with net sales up 8.8% year on year and operating profit up 65.8%.
  18. FY2020-Q2AdvancedAnnual report

    「At the subsidiary engaged in selling inserting machines, sales were recorded from large projects, among other factors. Net sales were ¥914 million, up 10.4% year on year, and operating profit was ¥71 million, up 134.0%.」

    In Other businesses, a large project at the inserting-machine sales subsidiary was recorded, with net sales up 10.4% year on year and operating profit up 134.0%.
  19. FY2020-Q1WorsenedAnnual report

    「The stagnation in sales at 2 subsidiaries, due in part to customers holding back orders following the change of era name and sluggish sales of inserting machines, resulted in revenue of ¥414 million, down 17.8% year on year, and operating profit of ¥15 million, down 64.9%.」

    In the Other business, sales at 2 subsidiaries stagnated, resulting in revenue down 17.8% year on year and operating profit down 64.9%.
  20. FY2019-Q3RestatedAnnual report

    「The poor performance of the subsidiary engaged in the manufacture and sale of inserting machines resulted in revenue of ¥1,217 million, down 13.9% year on year, and operating profit of ¥44 million, down 62.8%.」

    In the Other business, revenue and operating profit declined year on year due to the poor performance of the subsidiary engaged in the manufacture and sale of inserting machines. The weak conditions through the previous quarter continued.
  21. FY2019-Q2RestatedAnnual report

    「The poor performance of the subsidiary engaged in the manufacture and sale of inserting machines resulted in revenue of ¥828 million, down 12.8% year on year, and operating profit of ¥30 million, down 62.2%.」

    In the Other business, revenue and operating profit declined year on year due to the poor performance of the subsidiary engaged in the manufacture and sale of inserting machines.
  22. FY2019-Q1WorsenedAnnual report

    「The subsidiary engaged in the information systems business and the manufacture and sale of inserting machines performed poorly, resulting in revenue of ¥504 million, down 15.5% year on year, and operating profit of ¥43 million, down 50.0%.」

    The Other business performed poorly, with revenue down 15.5% and operating profit down 50.0%.
  23. FY2018RestatedAnnual report

    「The subsidiary engaged in the information systems business and the manufacture and sale of inserting machines performed steadily, resulting in revenue of ¥1,779 million, up 2.5% from the previous consolidated fiscal year. Operating profit was ¥104 million, down 8.9%, due in part to higher selling, general and administrative expenses at the subsidiary.」

    It states that the Other business performed steadily and that revenue increased, but operating profit declined due to higher selling, general and administrative expenses.
  24. FY2018-Q3AdvancedAnnual report

    「The subsidiary engaged in the information systems business and the manufacture and sale of inserting machines performed steadily, resulting in revenue of ¥1,413 million, up 11.4% year on year, and operating profit of ¥119 million, up 25.2%.」

    Revenue in the Other business increased 11.4% year on year and operating profit increased 25.2%, indicating continued improvement in profitability.
  25. FY2018-Q1AdvancedAnnual report

    「The subsidiary engaged in the manufacture and sale of inserting machines performed steadily in response to the trend toward larger mailings. Together with higher revenue and efforts to strengthen profitability across the business, this resulted in revenue of ¥597 million, up 16.8% year on year, and operating profit of ¥88 million, up 17.7%.」

    The Other business continued to strengthen profitability, with revenue up 16.8% year on year and operating profit up 17.7%.
  26. FY2017AdvancedAnnual report

    「In response to the trend toward larger mailings, the subsidiary engaged in the manufacture and sale of inserting machines performed steadily. Together with efforts to strengthen profitability across the business, this resulted in revenue of ¥1,736 million, up 4.3% from the previous consolidated fiscal year, and operating profit of ¥114 million, up 643.3%.」

    The Other business continued to strengthen profitability, with revenue up 4.3% year on year and operating profit increasing to ¥114 million.
  27. FY2017-Q3AdvancedAnnual report

    「In response to the trend toward larger mailings, the subsidiary engaged in the manufacture and sale of inserting machines performed steadily. Together with efforts to strengthen profitability across the business, this resulted in revenue of ¥1,269 million, up 4.6% year on year, and operating profit of ¥95 million, compared with an operating loss of ¥33 million in the same period of the previous year.」

    The Other business continued to strengthen profitability, with revenue up 4.6% year on year and operating profit of ¥95 million, remaining profitable compared with the operating loss in the same period of the previous year.
  28. FY2017-Q2AdvancedAnnual report

    「In response to the trend toward larger mailings, the subsidiary engaged in the manufacture and sale of inserting machines performed steadily. Together with efforts to strengthen profitability across the business, this resulted in revenue of ¥893 million, up 7.6% year on year, and operating profit of ¥83 million, compared with an operating loss of ¥30 million in the same period of the previous year.」

    It continued its policy of strengthening profitability, and the Other business turned from an operating loss in the same period of the previous year to operating profit of ¥83 million.
  29. FY2017-Q1First statedAnnual report

    「The subsidiary engaged in the information systems business and the manufacture and sale of inserting machines performed steadily, resulting in revenue of ¥559 million, up 19.1% year on year. In terms of profit and loss, operating profit was ¥66 million, compared with an operating loss of ¥21 million in the same period of the previous year, due in part to higher revenue and efforts to strengthen profitability.」

    For the Other business, it states that the Group worked to strengthen profitability in addition to increasing revenue.
Moved together

"Strengthening Initiatives in the Solutions Services Sector" moved the same way as this thread, in the same document, in 8 of its 29 moves.

865444★123456
  1. ★This thread
  2. 1Strengthening Initiatives in the Solutions Services Sector8×
  3. 2Transformation of the business structure centered on expanding business areas6×
  4. 3Improving efficiency across the production system5×
  5. 4Capital investment to support expansion of service areas and higher quality4×
  6. 5Control of raw material costs and in-house production4×
  7. 6Profit improvement in the envelope business through controlling expenses, including labor costs4×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Imura & yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.